PHARMACYTE BIOTECH, INC. Operating Expenses
PHARMACYTE BIOTECH, INC. (PMCB) reported Operating Expenses of $1.01 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. operating expenses for the quarter ending 2026-07-31 was $1.01M, a 18.67% increase year-over-year.
- PHARMACYTE BIOTECH, INC. operating expenses for the quarter ending 2026-04-30 was $2.51M, a 141.03% increase year-over-year.
- PHARMACYTE BIOTECH, INC. operating expenses for the quarter ending 2026-01-31 was $2.12M, a 120.58% increase year-over-year.
- PHARMACYTE BIOTECH, INC. operating expenses for the quarter ending 2025-10-31 was $1.38M, a 24.41% increase year-over-year.
- PHARMACYTE BIOTECH, INC. operating expenses for fiscal 2026 was $6.85M, a 56.55% increase from fiscal 2025.
- PHARMACYTE BIOTECH, INC. operating expenses for fiscal 2025 was $4.38M, a 48.62% decline from fiscal 2024.
- PHARMACYTE BIOTECH, INC. operating expenses for fiscal 2024 was $8.52M, a 31.98% increase from fiscal 2023.
- PHARMACYTE BIOTECH, INC. operating expenses for fiscal 2023 was $6.46M, a 46.98% increase from fiscal 2022.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | $1.01M 10-Q · filed 2026-09-14 | $3.52M derived: sum of 2 quarters · filed 2026-09-14 | $5.64M derived: sum of 3 quarters · filed 2026-09-14 | $7.01M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2026-04-30 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $4.63M derived: sum of 2 quarters · filed 2026-07-29 | $6.01M derived: sum of 3 quarters · filed 2026-07-29 | $6.85M 10-K · filed 2026-07-29 | |||
| 2026-01-31 | $2.12M 10-Q · filed 2026-03-17 | $3.49M derived: sum of 2 quarters · filed 2026-03-17 | $4.34M 10-Q · filed 2026-03-17 | $5.38M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2025-10-31 | $1.38M 10-Q · filed 2025-12-18 | $2.22M 10-Q · filed 2025-12-18 | $3.27M derived: sum of 3 quarters · filed 2026-09-14 | $4.23M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2025-07-31 | $848.30K 10-Q · filed 2026-09-14 | $1.89M derived: sum of 2 quarters · filed 2026-09-14 | $2.85M derived: sum of 3 quarters · filed 2026-09-14 | $3.96M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2025-04-30 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $2.00M derived: sum of 2 quarters · filed 2026-07-29 | $3.11M derived: sum of 3 quarters · filed 2026-07-29 | $4.38M 10-K · filed 2026-07-29 | |||
| 2025-01-31 | $960.25K 10-Q · filed 2026-03-17 | $2.07M derived: sum of 2 quarters · filed 2026-03-17 | $3.34M 10-Q · filed 2026-03-17 | $6.50M derived: sum of 4 quarters · filed 2026-03-17 | |||
| 2024-10-31 | $1.11M 10-Q · filed 2025-12-18 | $2.37M 10-Q · filed 2025-12-18 | $5.54M derived: sum of 3 quarters · filed 2025-12-18 | $7.41M derived: sum of 4 quarters · filed 2025-12-18 | |||
| 2024-07-31 | $1.27M 10-Q · filed 2025-09-15 | $4.44M derived: sum of 2 quarters · filed 2025-09-15 | $6.30M derived: sum of 3 quarters · filed 2025-09-15 | $7.71M derived: sum of 4 quarters · filed 2025-09-15 | |||
| 2024-04-30 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | $5.04M derived: sum of 2 quarters · filed 2025-08-11 | $6.44M derived: sum of 3 quarters · filed 2025-08-11 | $8.52M 10-K · filed 2025-08-11 | |||
| 2024-01-31 | $1.87M 10-Q · filed 2025-03-17 | $3.28M derived: sum of 2 quarters · filed 2025-03-17 | $5.35M 10-Q · filed 2025-03-17 | $6.26M derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2023-10-31 | $1.41M 10-Q · filed 2024-12-13 | $3.48M 10-Q · filed 2024-12-13 | $4.39M derived: sum of 3 quarters · filed 2024-12-13 | $5.94M derived: sum of 4 quarters · filed 2024-12-13 | |||
| 2023-07-31 | $2.08M 10-Q · filed 2024-09-17 | $2.98M derived: sum of 2 quarters · filed 2024-09-17 | $4.53M derived: sum of 3 quarters · filed 2024-09-17 | $6.85M derived: sum of 4 quarters · filed 2024-09-17 | |||
| 2023-04-30 | $903.28K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-13 | $2.46M derived: sum of 2 quarters · filed 2024-08-13 | $4.77M derived: sum of 3 quarters · filed 2024-08-13 | $6.46M 10-K · filed 2024-08-13 | |||
| 2023-01-31 | $1.55M 10-Q · filed 2024-03-18 | $3.87M derived: sum of 2 quarters · filed 2024-03-18 | $5.55M 10-Q · filed 2024-03-18 | $7.06M derived: sum of 4 quarters · filed 2024-03-18 | |||
| 2022-10-31 | $2.32M 10-Q · filed 2023-12-15 | $4.00M 10-Q · filed 2023-12-15 | $5.51M derived: sum of 3 quarters · filed 2023-12-15 | $6.36M derived: sum of 4 quarters · filed 2023-12-15 | |||
| 2022-07-31 | $1.68M 10-Q · filed 2023-09-18 | $3.19M derived: sum of 2 quarters · filed 2023-09-18 | $4.04M derived: sum of 3 quarters · filed 2023-09-18 | $5.05M derived: sum of 4 quarters · filed 2023-09-18 | |||
| 2022-04-30 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | $2.36M derived: sum of 2 quarters · filed 2023-07-31 | $3.37M derived: sum of 3 quarters · filed 2023-07-31 | $4.39M 10-K · filed 2023-07-31 | |||
| 2022-01-31 | $856.12K 10-Q · filed 2023-03-16 | $1.86M derived: sum of 2 quarters · filed 2023-03-16 | $2.88M 10-Q · filed 2023-03-16 | $3.92M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-10-31 | $1.00M 10-Q · filed 2022-12-14 | $2.03M 10-Q · filed 2022-12-14 | $3.06M derived: sum of 3 quarters · filed 2022-12-14 | $3.82M derived: sum of 4 quarters · filed 2022-12-14 | |||
| 2021-07-31 | $1.02M 10-Q · filed 2022-09-14 | $2.06M derived: sum of 2 quarters · filed 2022-09-14 | $2.82M derived: sum of 3 quarters · filed 2022-09-14 | $3.76M derived: sum of 4 quarters · filed 2022-09-14 | |||
| 2021-04-30 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | $1.79M derived: sum of 2 quarters · filed 2022-07-28 | $2.74M derived: sum of 3 quarters · filed 2022-07-28 | $3.62M 10-K · filed 2022-07-28 | |||
| 2021-01-31 | $756.85K 10-Q · filed 2022-03-15 | $1.71M derived: sum of 2 quarters · filed 2022-03-15 | $2.59M 10-Q · filed 2022-03-15 | $3.34M derived: sum of 4 quarters · filed 2022-03-15 | |||
| 2020-10-31 | $949.51K 10-Q · filed 2021-12-14 | $1.83M 10-Q · filed 2021-12-14 | $2.58M derived: sum of 3 quarters · filed 2021-12-14 | $3.46M derived: sum of 4 quarters · filed 2021-12-14 | |||
| 2020-07-31 | $881.68K 10-Q · filed 2021-09-14 | $1.63M derived: sum of 2 quarters · filed 2021-09-14 | $2.51M derived: sum of 3 quarters · filed 2021-09-14 | $3.57M derived: sum of 4 quarters · filed 2021-09-14 | |||
| 2020-04-30 | $749.89K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-10 | $1.63M derived: sum of 2 quarters · filed 2021-08-10 | $2.69M derived: sum of 3 quarters · filed 2021-08-10 | $3.83M 10-K · filed 2021-08-10 | |||
| 2020-01-31 | $875.31K 10-Q · filed 2021-03-12 | $1.94M derived: sum of 2 quarters · filed 2021-03-12 | $3.08M 10-Q · filed 2021-03-12 | $4.25M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-10-31 | $1.07M 10-Q · filed 2020-12-11 | $2.20M 10-Q · filed 2020-12-11 | $3.37M derived: sum of 3 quarters · filed 2020-12-11 | $4.05M derived: sum of 4 quarters · filed 2020-12-11 | |||
| 2019-07-31 | $1.13M 10-Q · filed 2020-09-11 | $2.31M derived: sum of 2 quarters · filed 2020-09-11 | $2.98M derived: sum of 3 quarters · filed 2020-09-11 | $4.02M derived: sum of 4 quarters · filed 2020-09-11 | |||
| 2019-04-30 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | $1.85M derived: sum of 2 quarters · filed 2020-08-13 | $2.89M derived: sum of 3 quarters · filed 2020-08-13 | $4.10M 10-K · filed 2020-08-13 | |||
| 2019-01-31 | $676.35K 10-Q · filed 2020-03-13 | $1.71M derived: sum of 2 quarters · filed 2020-03-13 | $2.93M 10-Q · filed 2020-03-13 | $4.38M derived: sum of 4 quarters · filed 2020-03-13 | |||
| 2018-10-31 | $1.04M 10-Q · filed 2019-12-23 | $2.25M 10-Q · filed 2019-12-23 | $3.70M derived: sum of 3 quarters · filed 2019-12-23 | $5.73M derived: sum of 4 quarters · filed 2019-12-23 | |||
| 2018-07-31 | $1.22M 10-Q · filed 2019-09-13 | $2.66M derived: sum of 2 quarters · filed 2019-09-13 | $4.69M derived: sum of 3 quarters · filed 2019-09-13 | $6.51M derived: sum of 4 quarters · filed 2019-09-13 | |||
| 2018-04-30 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | $3.48M derived: sum of 2 quarters · filed 2019-08-13 | $5.29M derived: sum of 3 quarters · filed 2019-08-13 | $6.98M 10-K · filed 2019-08-13 | |||
| 2018-01-31 | $2.03M 10-Q · filed 2019-03-14 | $3.84M derived: sum of 2 quarters · filed 2019-03-14 | $5.53M 10-Q · filed 2019-03-14 | $6.69M derived: sum of 4 quarters · filed 2019-03-14 | |||
| 2017-10-31 | $1.81M 10-Q · filed 2018-12-14 | $3.50M 10-Q · filed 2018-12-14 | $4.66M derived: sum of 3 quarters · filed 2018-12-14 | $5.94M derived: sum of 4 quarters · filed 2018-12-14 | |||
| 2017-07-31 | $1.69M 10-Q · filed 2018-09-12 | $2.84M derived: sum of 2 quarters · filed 2018-09-12 | $4.12M derived: sum of 3 quarters · filed 2018-09-12 | $5.10M derived: sum of 4 quarters · filed 2018-09-12 | |||
| 2017-04-30 | $1.15M 10-K · filed 2017-07-27 | $2.44M derived: sum of 2 quarters · filed 2018-03-19 | $3.41M derived: sum of 3 quarters · filed 2018-03-19 | $4.44M 10-K · filed 2018-07-20 | |||
| 2017-01-31 | $1.28M 10-Q · filed 2018-03-19 | $2.26M derived: sum of 2 quarters · filed 2018-03-19 | $3.29M 10-Q · filed 2018-03-19 | $4.42M derived: sum of 4 quarters · filed 2018-03-19 | |||
| 2016-10-31 | $974.20K 10-Q · filed 2017-12-14 | $2.01M 10-Q · filed 2017-12-14 | $3.14M derived: sum of 3 quarters · filed 2017-12-14 | $4.93M derived: sum of 4 quarters · filed 2017-12-14 | |||
| 2016-07-31 | $1.03M 10-Q · filed 2017-09-13 | $2.16M derived: sum of 2 quarters · filed 2017-09-13 | $3.95M derived: sum of 3 quarters · filed 2017-09-13 | $5.59M derived: sum of 4 quarters · filed 2017-09-13 | |||
| 2016-04-30 | $1.13M 10-K · filed 2017-07-27 | $2.92M derived: sum of 2 quarters · filed 2017-07-27 | $4.56M derived: sum of 3 quarters · filed 2017-07-27 | $6.07M 10-K · filed 2017-07-27 | |||
| 2016-01-31 | $1.79M 10-K · filed 2017-07-27 | $3.43M derived: sum of 2 quarters · filed 2017-07-27 | $4.94M 10-Q · filed 2017-03-13 | $8.96M derived: sum of 4 quarters · filed 2017-07-27 | |||
| 2015-10-31 | $1.64M 10-K · filed 2017-07-27 | $1.13M 10-Q · filed 2015-12-10 | $3.15M 10-Q · filed 2016-12-02 | $2.14M 10-Q · filed 2015-12-10 | $7.17M derived: sum of 3 quarters · filed 2017-07-27 | $8.63M derived: sum of 4 quarters · filed 2017-07-27 | |
| 2015-07-31 | $1.51M 10-K · filed 2017-07-27 | $1.01M 10-Q · filed 2015-08-25 | $5.53M derived: sum of 2 quarters · filed 2017-07-27 | $6.99M derived: sum of 3 quarters · filed 2017-07-27 | $13.19M derived: sum of 4 quarters · filed 2017-07-27 | ||
| 2015-04-30 | $4.02M 10-K · filed 2016-07-29 | $4.45M 10-K · filed 2015-07-29 | $5.48M derived: sum of 2 quarters · filed 2016-07-29 | $11.68M derived: sum of 3 quarters · filed 2016-07-29 | $13.26M 10-K · filed 2016-07-29 | $13.70M 10-K · filed 2015-07-29 | |
| 2015-01-31 | $1.46M 10-K · filed 2016-07-29 | $7.66M derived: sum of 2 quarters · filed 2016-07-29 | $9.29M 10-Q · filed 2016-03-08 | $25.69M derived: sum of 4 quarters · filed 2016-07-29 | |||
| 2014-10-31 | $6.20M 10-K · filed 2016-07-29 | $6.25M 10-Q · filed 2014-12-15 | $7.83M 10-Q/A · filed 2016-01-19 | $24.23M derived: sum of 3 quarters · filed 2016-07-29 | $24.91M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-07-31 | $1.58M 10-K · filed 2016-07-29 | $18.03M derived: sum of 2 quarters · filed 2016-07-29 | $18.71M derived: sum of 3 quarters · filed 2016-07-29 | $19.16M derived: sum of 4 quarters · filed 2016-07-29 | |||
| 2014-04-30 | $16.45M 10-K/A · filed 2016-01-19 | $17.13M derived: sum of 2 quarters · filed 2016-01-19 | $17.58M derived: sum of 3 quarters · filed 2016-01-19 | $18.98M 10-K · filed 2016-07-29 | |||
| 2014-01-31 | $681.08K 10-K/A · filed 2016-01-19 | $1.13M derived: sum of 2 quarters · filed 2016-01-19 | $2.53M 10-Q · filed 2015-03-13 | $2.99M derived: sum of 4 quarters · filed 2016-01-19 | |||
| 2013-10-31 | $448.57K 10-K/A · filed 2016-01-19 | $1.85M 10-Q · filed 2014-12-15 | $2.30M derived: sum of 3 quarters · filed 2016-01-19 | $2.65M derived: sum of 4 quarters · filed 2016-01-19 | |||
| 2013-07-31 | $1.40M 10-K/A · filed 2016-01-19 | $1.86M derived: sum of 2 quarters · filed 2016-01-19 | $2.20M derived: sum of 3 quarters · filed 2016-01-19 | $2.54M derived: sum of 4 quarters · filed 2016-01-19 | |||
| 2013-04-30 | $455.19K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $796.03K derived: sum of 2 quarters · filed 2016-01-19 | $1.14M derived: sum of 3 quarters · filed 2016-01-19 | $1.69M 10-K/A · filed 2016-01-19 | |||
| 2013-01-31 | $340.84K 10-Q · filed 2014-03-17 | $686.30K derived: sum of 2 quarters · filed 2014-03-17 | $1.23M 10-Q · filed 2014-03-17 | $1.73M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2012-10-31 | $345.46K 10-Q · filed 2013-12-16 | $890.88K 10-Q · filed 2013-12-16 | $1.38M derived: sum of 3 quarters · filed 2013-12-16 | $1.81M derived: sum of 4 quarters · filed 2013-12-16 | |||
| 2012-07-31 | $545.41K 10-Q · filed 2013-09-16 | $1.04M derived: sum of 2 quarters · filed 2013-09-16 | $1.47M derived: sum of 3 quarters · filed 2013-09-16 | $1.89M derived: sum of 4 quarters · filed 2013-09-16 | |||
| 2012-04-30 | $494.09K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $922.13K derived: sum of 2 quarters · filed 2013-07-29 | $1.34M derived: sum of 3 quarters · filed 2013-07-29 | $2.00M 10-K · filed 2013-07-29 | |||
| 2012-01-31 | $428.04K 10-Q · filed 2013-03-26 | $428.04K 10-Q · filed 2012-03-21 | $845.58K derived: sum of 2 quarters · filed 2013-03-26 | $1.50M 10-Q · filed 2013-03-26 | $1.77M derived: sum of 4 quarters · filed 2013-03-26 | ||
| 2011-10-31 | $417.54K 10-Q · filed 2012-12-26 | $1.07M 10-Q · filed 2012-12-26 | $1.35M derived: sum of 3 quarters · filed 2012-12-26 | $1.42M derived: sum of 4 quarters · filed 2012-12-26 | |||
| 2011-07-31 | $656.69K 10-Q · filed 2012-09-19 | $928.56K derived: sum of 2 quarters · filed 2012-09-19 | $1.01M derived: sum of 3 quarters · filed 2012-09-19 | $1.04M derived: sum of 4 quarters · filed 2012-09-19 | |||
| 2011-04-30 | $271.88K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-14 | $350.69K derived: sum of 2 quarters · filed 2012-08-14 | $382.89K derived: sum of 3 quarters · filed 2012-08-14 | $482.25K 10-K · filed 2012-08-14 | |||
| 2011-01-31 | $78.82K 10-Q · filed 2012-03-21 | $111.01K derived: sum of 2 quarters · filed 2012-03-21 | $210.38K 10-Q · filed 2012-03-21 | ||||
| 2010-10-31 | $32.19K 10-Q · filed 2011-12-15 | $131.56K 10-Q · filed 2011-12-15 | |||||
| 2010-07-31 | $99.37K 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |